NCT00547183

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil (2.5 mg and 5 mg) Administered Once Daily to Men With Diabetes Mellitus and Erectile Dysfunction

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 298 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Study to evaluate the safety and effectiveness of 2.5 mg and 5 mg tadalafil when taken by men with diabetes mellitus who have problems getting and maintaining an erection.

Conditions

• Impotence

Interventions

Type	Name	Description
DRUG	tadalafil	2.5 mg tadalafil tablet taken by mouth once a day, no more than 1 dose a day, for 12 weeks
DRUG	tadalafil	5 mg tadalafil tablet taken by mouth once a day, no more than 1 dose a day, for 12 weeks
DRUG	placebo	Placebo tablet taken by mouth once a day, no more than 1 dose per day, for 12 weeks

Timeline

• Start date: 2004-10-01
• Completion: 2005-05-01
• First posted: 2007-10-22
• Last updated: 2007-10-22

Locations

1 site across 1 country: Germany